In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4144-4148

  Domenech, Mirian ^a,b   Garciá, Ernesto ^a,b   Moscoso, Miriam ^a,b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLYSIN; BACTERIAL PROTEIN; CPL 1 PROTEIN; CPL 7 PROTEIN; HYDROLASE; LYTA PROTEIN; LYTC PROTEIN; N ACETYLMURAMOYLALANINE AMIDASE; PAL PROTEIN; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ARTICLE; AUTOLYSIS; BACTERIAL CELL WALL; BACTERIOPHAGE; BIOFILM; CELL WALL; IN VITRO STUDY; PLANKTON; PRIORITY JOURNAL; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PSEUDOPNEUMONIAE;

BIOFILMS; CELL WALL; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE;

EID: 80051828499     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00492-11     Document Type: Article

References (44)

1. Bustamante, N., et al. 2010. Cpl-7, a lysozyme encoded by a pneumococcal bacteriophage with a novel cell wall-binding motif. J. Biol. Chem. 285:33184-33196.
2. Costerton, J W, Z. Lewandowski, D E Caldwell, D R Korber, and H M Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
3. Croux, C., C. Ronda, R. López, and J L García. 1993. Role of the C-terminal domain of the lysozyme of Clostridium acetobutylicum ATCC 824 in a chimeric pneumococcal-clostridial cell wall lytic enzyme. FEBS Lett. 336:111-114. (Pubitemid 23362015)
4. Denapaite, D., et al. 2010. The genome of Streptococcus mitis B6 - what is a commensal? PLoS One 5:e9426.
5. Diaz, E., R. López, and J L Garcia. 1991. Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits. J. Biol. Chem. 266:5464-5471. (Pubitemid 21909517)
6. Díaz, E., R. López, and J L García. 1992. EJ-1, a temperate bacteriophage of Streptococcus pneumoniae with a Myoviridae morphotype. J. Bacteriol. 174:5516-5525.
7. Domenech, M., E. García, and M. Moscoso. 2009. Versatility of the capsular genes during biofilm formation by Streptococcus pneumoniae. Environ. Microbiol. 11:2542-2555.
8. Donlan, R M 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 17:66-72.
9. Eliopoulos, G, and R C J Moellering. 1996. Antimicrobial combinations, p. 330-396. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, MD.
10. Fischetti, V A 2010. Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens. Int. J. Med. Microbiol. 300:357-362.
11. Garcia-Bustos, J F, B T Chait, and A. Tomasz. 1987. Structure of the peptide network of pneumococcal peptidoglycan. J. Biol. Chem. 262:15400-15405.
12. García, P., J L García, E. García, J M Sánchez-Puelles, and R. López. 1990. Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 86:81-88. (Pubitemid 20082548)
13. García, P., M P González, E. García, J L García, and R. López. 1999. The molecular characterization of the first autolytic lysozyme of Streptococcus pneumoniae reveals evolutionary mobile domains. Mol. Microbiol. 33:128-138. (Pubitemid 29304194)
14. Hermoso, J A, J L García, and P. García. 2007. Taking aim on bacterial pathogens: From phage therapy to enzybiotics. Curr. Opin. Microbiol. 10:461-472. (Pubitemid 350064581)
15. Höltje, J V, and A. Tomasz. 1976. Purification of the pneumococcal N-acetylmuramyl-L-alanine amidase to biochemical homogeneity. J. Biol. Chem. 251:4199-4207.
16. Hoskins, J., et al. 2001. Genome of the bacterium Streptococcus pneumoniae strain R6. J. Bacteriol. 183:5709-5717. (Pubitemid 32898618)
17. Jado, I., et al. 2003. Phage lytic enzymes as therapy of antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J. Antimicrob. Chemother. 52:967-973.
18. Kutateladze, M, and R. Adamia. 2010. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28:591-595.
19. Lacks, S, and R D Hotchkiss. 1960. A study of the genetic material determining an enzyme activity in Pneumococcus. Biochim. Biophys. Acta 39:508-517.
20. Laemmli, U K 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
21. Lewis, K. 2008. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322:107-131.
22. Loeffler, J M, S. Djurkovic, and V A Fischetti. 2003. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun. 71:6199-6204. (Pubitemid 37337675)
23. López, R, and E. García. 2004. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol. Rev. 28:553-580. (Pubitemid 39469920)
24. López, R., E. García, and P. García. 2004. Enzymes for anti-infective therapy: Phage lysins. Drug Discov. Today Ther. Strateg. 1:469-474. (Pubitemid 40197593)
25. López, R., E. García, P. García, and J L García. 2004. Cell wall hydrolases, p. 75-88. In E. I. Tuomanen, T. J. Mitchell, D. A. Morrison, and B. G. Spratt (ed.), The pneumococcus. ASM Press, Washington, DC.
26. Maestro, B, and J M Sanz. 2007. Novel approaches to fight Streptococcus pneumoniae. Recent Pat. Antiinfect. Drug Discov. 2:188-196.
27. McCullers, J A, Å Karlström, A R Iverson, J M Loeffler, and V A Fischetti. 2007. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog. 3:e28.
28. Moscoso, M., M. Domenech, and E. García. 2010. Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide. Mol. Microbiol. 77:1052-1064.
29. Moscoso, M., E. García, and R. López. 2006. Biofilm formation by Streptococcus pneumoniae: Role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J. Bacteriol. 188:7785-7795. (Pubitemid 44764515)
30. Moscoso, M., E. García, and R. López. 2009. Pneumococcal biofilms. Int. Microbiol. 12:77-85.
31. Rodríguez-Cerrato, V., et al. 2007. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. J. Antimicrob. Chemother. 60:1159-1162. (Pubitemid 47617771)
32. Rodríguez-Cerrato, V., et al. 2007. Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly β-lactam-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51:3371-3373. (Pubitemid 350067555)
33. Sambrook, J., E F Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
34. Sánchez-Puelles, J M, J M Sanz, J L García, and E. García. 1992. Immobilization and single-step purification of fusion proteins using DEAE-cellulose. Eur. J. Biochem. 203:153-159.
35. Sanz, J M, E. Díaz, and J L García. 1992. Studies on the structure and function of the N-terminal domain of the pneumococcal murein hydrolases. Mol. Microbiol. 6:921-931.
36. Sass, P, and G. Bierbaum. 2007. Lytic activity of recombinant bacteriophage φ11 and φ12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl. Environ. Microbiol. 73:347-352. (Pubitemid 46079972)
37. Sheehan, M M, J L García, R. López, and P. García. 1997. The lytic enzyme of the pneumococcal phage Dp-1: A chimeric lysin of intergeneric origin. Mol. Microbiol. 25:717-725. (Pubitemid 27394569)
38. Son, J-S, et al. 2010. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Appl. Microbiol. Biotechnol. 86:1439-1449.
39. Soriano, F., P. García-Corbeira, C. Ponte, R. Fernández- Roblas, and I. Gadea. 1996. Correlation of pharmacodynamic parameters of five β-lactam antibiotics with therapeutic efficacies in an animal model. Antimicrob. Agents Chemother. 40:2686-2690. (Pubitemid 26404326)
40. B is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48:1075-1087.
41. Vollmer, W, and A. Tomasz. 2000. The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J. Biol. Chem. 275:20496-20501. (Pubitemid 30457629)
42. Weiser, J N 2010. The pneumococcus: Why a commensal misbehaves. J. Mol. Med. 88:97-102.
43. Witzenrath, M., et al. 2009. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit. Care Med. 37:642-649.
44. Wolcott, R D, and G D Ehrlich. 2008. Biofilms and chronic infections. JAMA 299:2682-2684. (Pubitemid 351831599)